Carregant...
Evaluation of Oritavancin Use at a Community Hospital
Background: Oritavancin is a lipoglycopeptide antibiotic indicated for the treatment of acute bacterial skin and soft tissue infections. The prolonged half-life of this agent allows for a course of therapy to be completed with a single dose. Oritavancin was added to our formulary as an option for tr...
Guardat en:
| Publicat a: | Hosp Pharm |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
SAGE Publications
2017
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6050883/ https://ncbi.nlm.nih.gov/pubmed/30038448 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/0018578717746415 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|